APC and NIBRT Announce Strategic Partnership
APC and NIBRT enter Strategic Partnership to enhance client access to their respective Biopharmaceutical Services
2nd April 2019 (Dublin, Ireland):
The Applied Process Company Ltd., hereafter referred to as APC, and the National Institute for Bioprocessing Research & Training, hereafter referred to as NIBRT, today announced the signing of a strategic partnership agreement to provide their respective client bases with increased access to research, development and analytical services across their complementary biopharmaceutical services. This move represents both Parties’ ongoing commitment to address the growing needs of their clients by providing state-of-the-art process development, training and bioanalytical capabilities.
APC have been successfully utilising NIBRT’s expertise to complement its own analytical development services in certain areas for several years. This agreement sees the Parties deepen that relationship to offer their combined client base access to the broader complementary services. This collaborative arrangement will enable both Parties to act as a point of referral for clients requiring expert process development and biopharmaceutical services.
Leveraging APC’s market leading process development and optimization services through application of its state-of-the-art process analytical technology (PAT), coupled to NIBRT’s extensive biopharmaceutical services and knowledge in single use, pilot plant and bioanalytical capabilities, the partnership will better serve the complex needs of the shared client base.
Commenting on this development, APC Chief Commercial Officer Mr. David Downey said: “We welcome this logical extension to our current relationship with NIBRT and recognise the value of their biopharmaceutical services, complementing our own in-house bioprocess development and optimization technologies, which have recently benefited from multimillion-euro investment. This mutually beneficial arrangement will further increase our capabilities in delivering complex process development solutions to our global client base.”
Mr. Killian O’Driscoll, Director of Projects at NIBRT, commented: “Our global client base has complex bioanalytical characterization and process development requirements to support their development of their innovative therapeutics. We’re delighted to announce the further strengthening of our partnership with APC to assist clients design, develop and characterise their biological processes and products. This will help optimise the cost and time to develop and launch these medicines to the highest quality standards.”
Accelerating the development of quality life-changing medicines to patients, APC utilises its state-of-the-art technology platforms (ACHIEVE® and BioACHIEVE®) across chemical and biological molecules to reduce time, cost and risk for your product. Headquartered in Dublin and partnering with 8 of the top-10 global pharmaceutical, and 5 of the top-10 biopharmaceutical companies, APC provides its services globally. Employing the best and brightest in the fields of Chemical, Biochemical and Process Engineering, APC design, develop and optimise manufacturing processes. APC combines technologies ranging from process modelling, automated lab reactors and process analytical technology (PAT) with in-house developed capabilities in continuous processing, process control and advanced analytics to empower the development of synthetic and biologic medicines.
The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in biopharmaceutical manufacturing. NIBRT is located in a world class facility in Dublin, Ireland. This facility is purpose built to closely replicate a modern bioprocessing plant with state-of the art equipment and enables NIBRT to offer the highest quality training and research solutions. NIBRT’s mission is to support the growth and development of all aspects of the biopharmaceutical manufacturing industry.